Thomas Eissenberg
Overview
Explore the profile of Thomas Eissenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
7828
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alzoubi K, Khabour O, Al-Sawalha N, Al Momany E, Jarab A, Haddad R, et al.
Curr Neuropharmacol
. 2025 Feb;
PMID: 39936419
Introduction: E-cigarettes (EC) have been shown to impair memory by disrupting the balance involving ROS and antioxidant enzymes, leading to oxidative stress. Vitamin C (VitC) is a strong antioxidant with...
2.
Hardesty J, Crespi E, Sinamo J, Nian Q, Breland A, Eissenberg T, et al.
J Med Internet Res
. 2024 Dec;
26:e60184.
PMID: 39680887
In 2019, we launched a web-based longitudinal survey of adults who frequently use e-cigarettes, called the Vaping and Patterns of E-cigarette Use Research (VAPER) Study. The initial attempt to collect...
3.
Robinson J, Cui Y, Kypriotakis G, Engelmann J, Karam-Hage M, Minnix J, et al.
Exp Clin Psychopharmacol
. 2024 Nov;
PMID: 39541521
The U.S. Food and Drug Administration has stated its intention to reduce the nicotine content of combustible cigarettes to render them less addictive. This study evaluated the impact of providing...
4.
Yaseen A, Alzoubi K, Al-Sawalha N, Khabour O, Jarab A, Ali S, et al.
Neurotoxicology
. 2024 Nov;
105:263-271.
PMID: 39488233
The use of electronic cigarettes (ECIGs) has grown exponentially among young adolescents. Tobacco smoking, in general and ECIG use in particular, has been linked to disruption of the oxidative system,...
5.
Snell L, Barnes A, Eissenberg T
Nicotine Tob Res
. 2024 Oct;
PMID: 39404138
Introduction: Older adults who smoke face significant risk of tobacco-related disease and hold misperceptions about health risks posed by nicotine product use. This study examined whether socioeconomic status and race...
6.
El Hourani M, Lakkis I, Ammar M, AlGemayel C, Talih S, Golshahi L, et al.
Tob Control
. 2024 Oct;
PMID: 39375033
Background: For decades, the tobacco industry has engineered the sensory characteristics of combustible tobacco products including the degree of harshness experienced at the back of the throat. Commonly referred to...
7.
Eissenberg T, Shihadeh A
Tob Control
. 2024 Jun;
PMID: 38897725
Electronic nicotine delivery systems (ENDS) may lead to public health benefit if they help people who smoke quit smoking, and may lead to public health harm if they recruit a...
8.
Soule E, Rossheim M, Livingston M, LoParco C, Tillett K, Eissenberg T, et al.
Tob Control
. 2024 Jun;
PMID: 38862233
Electronic cigarette (e-cigarette) use has increased since e-cigarettes were introduced to the market nearly 20 years ago. Researchers continue to conduct studies to understand the health risks and benefits of...
9.
Patev A, Combs M, Gaitan N, Karaoghlanian N, Lipato T, Eissenberg T, et al.
Exp Clin Psychopharmacol
. 2024 May;
32(5):604-614.
PMID: 38815113
Nicotine flux, the rate of electronic nicotine delivery system (ENDS) nicotine emission, is important in determining ENDS abuse liability. However, flux does not account for user behavior, including puff duration....
10.
Maloney S, Hoetger C, Bono R, Lester Scholtes R, Combs M, Karaoghlanian N, et al.
Exp Clin Psychopharmacol
. 2024 May;
32(5):588-603.
PMID: 38815111
Despite the popularity of electronic cigarettes (ECIGs), limited research has examined the role of sweeteners, independent of other flavors, in shaping ECIG human abuse potential (HAP). This study examined the...